Eiger BioPharmaceuticals Overview
Eiger BioPharmaceuticals Discounted Cash Flow
DCF Analysis for EIGR.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.95
Current Fair Value
$2.95
↑ 71.3% Upside
Undervalued by 71.3% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison